Shopping Cart
- Remove All
 
Your shopping cart is currently empty
ZJCK-6-46 (32) is a potential orally active DYRK1A inhibitor (IC50= 0.68 nM) with favorable CNC permeability. It downregulates tau phosphorylation and improves cognitive impairments by significantly reducing the expression of phosphorylated tau proteins and neuronal loss.
| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 10 mg | Inquiry | Backorder | |
| 50 mg | Inquiry | Backorder | 
| Description | ZJCK-6-46 (32) is a potential orally active DYRK1A inhibitor (IC50= 0.68 nM) with favorable CNC permeability. It downregulates tau phosphorylation and improves cognitive impairments by significantly reducing the expression of phosphorylated tau proteins and neuronal loss.  | 
| Targets&IC50 |  CLK1:1.68 nM, DYRK4:401.3 nM, CLK4:1.80 nM, DYRK2:14.18 nM, DYRK3:17.48 nM, CLK3:38.91 nM, DYRK1A:0.68 nM, DYRK1B:1.02 nM  | 
| In vivo | ZJCK-6-46 (32, 20-30 mg/kg, orally, OA-induced (MOD) mice) significantly reduces the expression of p-Tau thr212 in the CA1 and DG regions of mice induced by OA (Okadaic acid).  | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.